MedPath

Long Term Complications in Head and Neck Cancer Patients

Not Applicable
Conditions
Head-and-neck Cancer
Interventions
Diagnostic Test: Ultrasonography
Diagnostic Test: MRI
Diagnostic Test: Neuro Psychological Assessment Battery
Diagnostic Test: Questionaires
Registration Number
NCT04257968
Lead Sponsor
Radboud University Medical Center
Brief Summary

Problem:

With increasing numbers of cancer survivors, strategies to prevent long-term complications in cancer patients become more important. Adolescent and Young Adult (AYA) Head and Neck Cancer survivors treated with radiotheray (RT) are prone to long-term complications, especially vascular and psychosocial complications. Although several studies point to the importance of these long-term complications, structured survivorship care for AYA HNC survivors is still lacking.

Primary objective:

To investigate in AYA HNC survivors treated with unilateral RT at least 5 years before, the long-term vascular complications in terms of carotid wall changes (ultrasonography, MRI), cerebral vascular complications ((silent)brain infarctions, white matter lesions) and Cardiovascular Risk Management profile.

Secondary objective:

To investigate in AYA HNC survivors treated with unilateral RT at least 5 years before, the long-term psychosocial complications (subjective memory complaints, Depression, Anxiety, Fatigue, Speach handicap, Anxiety for recurrence, Quality of Life, objective cognitive failure)

Study design Prospective cohort study.

Patient population AYA HNC survivors ≥ 5 years after unilateral RT, either alone or in combination with surgery and/or chemotherapy.

Controls The ultrasonography (Intima Media Thickness, elastography) and MRI measurements of the irradiated carotid wall will be compared to the non-irradiated carotid wall. Cognitive performance will be compared to normative data. The cognitive performances of the right hemisphere tests will be compared to the cognitive performances of the left hemisphere tests. The frequency of silent brain infarcts and vascular white matter lesions of the irradiated vascular territory will be compared with the non-irradiated territory.

Intervention Structured survivorship care ≥ 5 years after RT conform the Personalized Cancer Survivorship Care Model of the Radboudumc Expertisecenter of late effects after cancer, complemented with carotid ultrasonography (IMT and elastography), MRI of the carotid arteries and brain), neuropsychological assessment battery and self-reported questionnaires concerning depression, fatigue, QoL, positive health and employment status.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • HNC patient treated with unilateral RT at age 18-40 years 5-10 years before
  • Informed Consent
Read More
Exclusion Criteria
  • Contra indication MRI
  • Able to communicate in Dutch language
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diagnostic interventionNeuro Psychological Assessment BatteryComplete diagnostic intervention
Diagnostic interventionUltrasonographyComplete diagnostic intervention
Diagnostic interventionMRIComplete diagnostic intervention
Diagnostic interventionQuestionairesComplete diagnostic intervention
Primary Outcome Measures
NameTimeMethod
Carotid wall thickness on MRI (mm)5-10 years after radiotherapy

Carotid wall thickness in mm on MRI in the irradiated versus the non-irradiated artery

Cardiovascular risk management: Body Mass Index5-10 years after radiotherapy

weight and height will be combined to report BMI in kg/m\^2

White matter hyperintensities on MRI5-10 years after radiotherapy

Volume of white matter hyperintensities on FLAIR in ml

Number of brain infarctions on MRI5-10 years after radiotherapy

Number of brain infarctions assessed on MRI

Intima Media Thickness (mm)5-10 years after radiotherapy

Intima Media thickness in mm on ultrasonography in the irradiated versus the non irradiated carotid artery

Pack Years smoking5-10 years after radiotherapy

Pack Years smoking

Hypertension5-10 years after radiotherapy

Definition: Systolic Bloodpressure \> 140 mmHg or taking antihypertensive medication

Carotid wall elastography5-10 years after radiotherapy

Carotid wall elastography on ultrasonography in the irradiated versus the non-irradiated artery:

distense coëfficiënt, pulse wave velocity (PWV) (during diastole and systole) and shear wave velocity (SWV) (2-8 moments during heartbeat)

Radiological characteristics of carotid wall changes on MRI5-10 years after radiotherapy

Radiological characteristics of carotid wall changes on MRI of the irradiated versus the non-irradiated artery: intensity on T1/T2/FLAIR/Proton Density.

Secondary Outcome Measures
NameTimeMethod
Cancer specific distress5-10 years after radiotherapy

Assessed by Impact of Event Scale-Revised, which is a 22-items scale and includes subscales of intrusion, sleep disturbance, hyperarousal, avoidance and numbing. Items are scored on a 5-point scale, ranging from 0 (not at all) to 4 (extremely).

Hospital Anxiety and Depression Scale (HADS).5-10 years after radiotherapy

Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety.

14 items Score depression: Range 0-21 Score Anxiety: Range 0-21 Total score: Range 0-42

Fatigue severity5-10 years after radiotherapy

Fatigue severity was assessed using the Checklist Individual Strength (CIS20R), a 20-item questionnaire that takes around five to ten minutes to fill out. Each question has a statement to be scored on a 7-point Likert scale ranging between 'yes, this is true' to 'no, this is not true'. The total score is calculated as the sum of the responses to the different statements. The maximum CIS20R score is 140, with a score of 76/140 or higher indicating that the patient is at risk for prolonged absence at work. The scale is subdivided in four dimensions of fatigue being fatigue severity (8 items, max. score 56), concentration problems (5 items, max. score 35), reduced motivation (4 items, max. score 28) and activity (3 items, max. score 21).

Total score: Range 20-140

Cognitive function5-10 years after radiotherapy

Cognitive function per cognitive domain:

Available normative data will be used to convert the patients results on the neuropsychological tests into standardized T scores (mean, SD), adjusted for age, sex and education.

Speech Handicap Index (SHI)5-10 years after radiotherapy

Assessed by Speech Handicap Index:

a questionairre assessing self perceived speech function. 30 items A total SHI can be calculated ranging from 0-120, with higher scores indicating more speech problems and with a cutoff value of 6 being able to identify patients with speech problems in daily life.

Fear of recurrence5-10 years after radiotherapy

Assessed by the Cancer Worry Scale (CWS):

self reported 8-item scale, measuring worry about the risk of cancer recurrence and its impact on daily functioning. Total score ranges from 8 to 32. Higher scores indicate higher FCR. A cutoff score of 13 vs 14 (low FCR 13 or lower; high FCR 14 or more) has been established to differentiate between those with normal FCR from those with bothersome levels of FCR. This cutoff had been validated relative to the Fear of Cancer Recurrence Inventory cutoff score, which is a validated maesure.

Subjective Memory Complaints5-10 years after radiotherapy

Assessed by Cognitive Failure Questionairre:

a questionairre about failures in perception, attention, memory, and motor function.

29 items Total score Range 0-100

Quality of Life5-10 years after radiotherapy

Assessed using the EORTC-QLQ-C30 questionairre consisting of 30 items. Total score: Range 0-100

Brief symptoms Inventory (BSI)5-10 years after radiotherapy

Assessed by Brief Symptom Inventory measure Brief Symptom Inventory (BSI) measure consists of 18 emotional distress items that are rated on a 5 point Likert scale and yield a Global Severity Index as well as Symptom Dimensions (Somatization, Depression, Anxiety.

Total score: Range 0-72

Trial Locations

Locations (1)

Radboudumc

🇳🇱

Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath